About Amgen

Amgen uses living cells to create biologic medicines that address serious diseases with limited treatment options. The company focuses on four therapeutic areas: oncology, inflammation, general medicine, and rare disease, reaching millions of patients across approximately 100 countries through therapies designed to restore health or save lives. Since 1980, Amgen has built its strategy on a simple belief: innovative, highly differentiated medicines that provide large clinical benefits not only help patients but also reduce the social and economic burden of disease in society, creating value through scientific rigor and patient focus.